BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brown RAM, Richardson KL, Kabir TD, Trinder D, Ganss R, Leedman PJ. Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology. Front Oncol 2020;10:476. [PMID: 32328462 DOI: 10.3389/fonc.2020.00476] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
Number Citing Articles
1 Skrajnowska D, Jagielska A, Ruszczyńska A, Wagner B, Bielecki W, Bobrowska-Korczak B. Title Changes in the Mineral Composition of Rat Femoral Bones Induced by Implantation of LNCaP Prostate Cancer Cells and Dietary Supplementation. Nutrients 2020;13:E100. [PMID: 33396969 DOI: 10.3390/nu13010100] [Reference Citation Analysis]
2 Bedhiafi T, Inchakalody VP, Fernandes Q, Mestiri S, Billa N, Uddin S, Merhi M, Dermime S. The potential role of vitamin C in empowering cancer immunotherapy. Biomed Pharmacother 2021;146:112553. [PMID: 34923342 DOI: 10.1016/j.biopha.2021.112553] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
3 Chavez-Dominguez R, Perez-Medina M, Aguilar-Cazares D, Galicia-Velasco M, Meneses-Flores M, Islas-Vazquez L, Camarena A, Lopez-Gonzalez JS. Old and New Players of Inflammation and Their Relationship With Cancer Development. Front Oncol 2021;11:722999. [PMID: 34881173 DOI: 10.3389/fonc.2021.722999] [Reference Citation Analysis]
4 Ramírez-Carmona W, Díaz-Fabregat B, Yuri Yoshigae A, Musa de Aquino A, Scarano WR, de Souza Castilho AC, Avansini Marsicano J, Leal do Prado R, Pessan JP, de Oliveira Mendes L. Are Serum Ferritin Levels a Reliable Cancer Biomarker? A Systematic Review and Meta-Analysis. Nutr Cancer 2021;:1-10. [PMID: 34607491 DOI: 10.1080/01635581.2021.1982996] [Reference Citation Analysis]
5 Zhu L, Meng D, Wang X, Chen X. Ferroptosis-Driven Nanotherapeutics to Reverse Drug Resistance in Tumor Microenvironment. ACS Appl Bio Mater 2022. [PMID: 35614872 DOI: 10.1021/acsabm.2c00199] [Reference Citation Analysis]
6 Orrego MA, Vasquez CM, Togneri K, Laclette JP, Garcia HH, Nash TE; Cysticercosis Working Group in Peru. Increased iron uptake in the bladder wall of racemose cysts of Taenia solium. Mol Biochem Parasitol 2022;251:111496. [PMID: 35830923 DOI: 10.1016/j.molbiopara.2022.111496] [Reference Citation Analysis]
7 Grzywa TM, Justyniarska M, Nowis D, Golab J. Tumor Immune Evasion Induced by Dysregulation of Erythroid Progenitor Cells Development. Cancers (Basel) 2021;13:870. [PMID: 33669537 DOI: 10.3390/cancers13040870] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ginefra P, Carrasco Hope H, Spagna M, Zecchillo A, Vannini N. Ionic Regulation of T-Cell Function and Anti-Tumour Immunity. Int J Mol Sci 2021;22:13668. [PMID: 34948472 DOI: 10.3390/ijms222413668] [Reference Citation Analysis]
9 Loh D, Reiter RJ. Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance. Molecules 2022;27:705. [PMID: 35163973 DOI: 10.3390/molecules27030705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Bileck A, Bortel P, Kriz M, Janker L, Kiss E, Gerner C, Del Favero G. Inward Outward Signaling in Ovarian Cancer: Morpho-Phospho-Proteomic Profiling Upon Application of Hypoxia and Shear Stress Characterizes the Adaptive Plasticity of OVCAR-3 and SKOV-3 Cells. Front Oncol 2022;11:746411. [DOI: 10.3389/fonc.2021.746411] [Reference Citation Analysis]
11 Yang F, Wu Z, Dai D, Zhang L, Zhang X, Zhang X, Xu Y. The iron chelator deferoxamine decreases myeloma cell survival. J Int Med Res 2021;49:300060520987396. [PMID: 33478296 DOI: 10.1177/0300060520987396] [Reference Citation Analysis]
12 Aksan A, Farrag K, Aksan S, Schroeder O, Stein J. Flipside of the Coin: Iron Deficiency and Colorectal Cancer. Front Immunol 2021;12:635899. [PMID: 33777027 DOI: 10.3389/fimmu.2021.635899] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Shi J, Lai D, Zuo X, Liu D, Chen B, Zheng Y, Lu C, Gu X. Identification of Ferroptosis-Related Biomarkers for Prognosis and Immunotherapy in Patients With Glioma. Front Cell Dev Biol 2022;10:817643. [PMID: 35174152 DOI: 10.3389/fcell.2022.817643] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Hsu MY, Mina E, Roetto A, Porporato PE. Iron: An Essential Element of Cancer Metabolism. Cells 2020;9:E2591. [PMID: 33287315 DOI: 10.3390/cells9122591] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
15 Harismah K, Hajali N, Zandi H. 6-Thioguanine bimolecular formation for dual chelation of iron: DFT study. Computational and Theoretical Chemistry 2021;1202:113308. [DOI: 10.1016/j.comptc.2021.113308] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Azemin WA, Alias N, Ali AM, Shamsir MS. Structural and functional characterisation of HepTH1-5 peptide as a potential hepcidin replacement. J Biomol Struct Dyn 2021;:1-24. [PMID: 34870559 DOI: 10.1080/07391102.2021.2011415] [Reference Citation Analysis]
17 Haferkamp S, Drexler K, Federlin M, Schlitt HJ, Berneburg M, Adamski J, Gaumann A, Geissler EK, Ganapathy V, Parkinson EK, Mycielska ME. Extracellular Citrate Fuels Cancer Cell Metabolism and Growth. Front Cell Dev Biol 2020;8:602476. [PMID: 33425906 DOI: 10.3389/fcell.2020.602476] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
18 Szarka A, Lőrincz T, Hajdinák P. Friend or Foe: The Relativity of (Anti)oxidative Agents and Pathways. IJMS 2022;23:5188. [DOI: 10.3390/ijms23095188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Basak T, Kanwar RK. Iron imbalance in cancer: Intersection of deficiency and overload. Cancer Med 2022. [PMID: 35460205 DOI: 10.1002/cam4.4761] [Reference Citation Analysis]
20 Mostafa N, Salem A, Mansour SZ, El-Sonbaty SM, Moawed FSM, Kandil EI. Rationale for Tailoring an Alternative Oncology Trial Using a Novel Gallium-Based Nanocomplex: Mechanistic Insights and Preclinical Challenges. Technol Cancer Res Treat 2022;21:15330338221085376. [PMID: 35382635 DOI: 10.1177/15330338221085376] [Reference Citation Analysis]
21 Wu G, Wang Q, Xu Y, Li Q, Cheng L. A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma. Aging (Albany NY) 2020;12:14933-48. [PMID: 32688345 DOI: 10.18632/aging.103553] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
22 Fnu G, Weber GF. Alterations of Ion Homeostasis in Cancer Metastasis: Implications for Treatment. Front Oncol 2021;11:765329. [PMID: 34988012 DOI: 10.3389/fonc.2021.765329] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Kodagoda Gamage SM, Islam F, Cheng T, Aktar S, Lu CT, Ranaweera CD, Lee KTW, Dissabandara L, Gopalan V, Lam AK. HFE variants in colorectal cancer and their clinicopathological correlations. Hum Pathol 2021;117:9-30. [PMID: 34371060 DOI: 10.1016/j.humpath.2021.07.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Battaglia AM, Sacco A, Perrotta ID, Faniello MC, Scalise M, Torella D, Levi S, Costanzo F, Biamonte F. Iron Administration Overcomes Resistance to Erastin-Mediated Ferroptosis in Ovarian Cancer Cells. Front Oncol 2022;12:868351. [DOI: 10.3389/fonc.2022.868351] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Hong-bin S, Wan-jun Y, Chen-hui D, Xiao-jie Y, Shen-song L, Peng Z. Identification of an Iron Metabolism-Related lncRNA Signature for Predicting Osteosarcoma Survival and Immune Landscape. Front Genet 2022;13:816460. [DOI: 10.3389/fgene.2022.816460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Szlasa W, Gachowska M, Kiszka K, Rakoczy K, Kiełbik A, Wala K, Puchała J, Chorążykiewicz K, Saczko J, Kulbacka J. Iron chelates in the anticancer therapy. Chem Pap . [DOI: 10.1007/s11696-021-02001-2] [Reference Citation Analysis]
27 Shen L, Lin D, Li X, Wu H, Lenahan C, Pan Y, Xu W, Chen Y, Shao A, Zhang J. Ferroptosis in Acute Central Nervous System Injuries: The Future Direction? Front Cell Dev Biol 2020;8:594. [PMID: 32760721 DOI: 10.3389/fcell.2020.00594] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
28 Buschhaus JM, Rajendran S, Humphries BA, Cutter AC, Muñiz AJ, Ciavattone NG, Buschhaus AM, Cañeque T, Nwosu ZC, Sahoo D, Bevoor AS, Shah YM, Lyssiotis CA, Ghosh P, Wicha MS, Rodriguez R, Luker GD. Effects of iron modulation on mesenchymal stem cell-induced drug resistance in estrogen receptor-positive breast cancer. Oncogene 2022. [PMID: 35732800 DOI: 10.1038/s41388-022-02385-9] [Reference Citation Analysis]
29 Ali A, Shafarin J, Unnikannan H, Al-Jabi N, Jabal RA, Bajbouj K, Muhammad JS, Hamad M. Co-targeting BET bromodomain BRD4 and RAC1 suppresses growth, stemness and tumorigenesis by disrupting the c-MYC-G9a-FTH1axis and downregulating HDAC1 in molecular subtypes of breast cancer. Int J Biol Sci 2021;17:4474-92. [PMID: 34803511 DOI: 10.7150/ijbs.62236] [Reference Citation Analysis]
30 He Y, Deng P, Yan Y, Zhu L, Chen H, Li T, Li Y, Li J. Matrisome provides a supportive microenvironment for oral squamous cell carcinoma progression. J Proteomics 2021;253:104454. [PMID: 34922012 DOI: 10.1016/j.jprot.2021.104454] [Reference Citation Analysis]
31 Zhang Z, Papa Akuetteh PD, Lin L, Wu Y, Li Y, Huang W, Ni H, Lv H, Zhang Q. Development and validation of a ferroptosis-related model for three digestive tract tumors based on a pan-cancer analysis. Epigenomics 2021;13:1497-514. [PMID: 34581636 DOI: 10.2217/epi-2021-0261] [Reference Citation Analysis]
32 Hu ZW, Chen L, Ma RQ, Wei FQ, Wen YH, Zeng XL, Sun W, Wen WP. Comprehensive analysis of ferritin subunits expression and positive correlations with tumor-associated macrophages and T regulatory cells infiltration in most solid tumors. Aging (Albany NY) 2021;13:11491-506. [PMID: 33864445 DOI: 10.18632/aging.202841] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Liu S, Cao X, Wang D, Zhu H. Iron metabolism: State of the art in hypoxic cancer cell biology. Archives of Biochemistry and Biophysics 2022. [DOI: 10.1016/j.abb.2022.109199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Wang Y, Tang B, Zhu J, Yu J, Hui J, Xia S, Ji J. Emerging Mechanisms and Targeted Therapy of Ferroptosis in Neurological Diseases and Neuro-oncology. Int J Biol Sci 2022;18:4260-74. [PMID: 35844784 DOI: 10.7150/ijbs.72251] [Reference Citation Analysis]
35 Al-Hassi HO, Ng O, Evstatiev R, Mangalika M, Worton N, Jambrich M, Khare V, Phipps O, Keeler B, Gasche C, Acheson AG, Brookes MJ. Intravenous iron is non-inferior to oral iron regarding cell growth and iron metabolism in colorectal cancer associated with iron-deficiency anaemia. Sci Rep 2021;11:13699. [PMID: 34211054 DOI: 10.1038/s41598-021-93155-2] [Reference Citation Analysis]
36 Olivo E, La Chimia M, Ceramella J, Catalano A, Chiaradonna F, Sinicropi MS, Cuda G, Iacopetta D, Scumaci D. Moving beyond the Tip of the Iceberg: DJ-1 Implications in Cancer Metabolism. Cells 2022;11:1432. [PMID: 35563738 DOI: 10.3390/cells11091432] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Li J, Hu C, Du Y, Tang X, Shao C, Xu T, Zhao Z, Hu H, Sheng Y, Guo J, Xi Y. Identification of Iron Metabolism-Related Gene Signatures for Predicting the Prognosis of Patients With Sarcomas. Front Oncol 2020;10:599816. [PMID: 33489900 DOI: 10.3389/fonc.2020.599816] [Reference Citation Analysis]
38 Gąbka M, Dałek P, Przybyło M, Gackowski D, Oliński R, Langner M. The Membrane Electrical Potential and Intracellular pH as Factors Influencing Intracellular Ascorbate Concentration and Their Role in Cancer Treatment. Cells 2021;10:2964. [PMID: 34831187 DOI: 10.3390/cells10112964] [Reference Citation Analysis]
39 Rizzollo F, More S, Vangheluwe P, Agostinis P. The lysosome as a master regulator of iron metabolism. Trends Biochem Sci 2021:S0968-0004(21)00159-6. [PMID: 34384657 DOI: 10.1016/j.tibs.2021.07.003] [Reference Citation Analysis]
40 Xu F, Zhang Z, Zhao Y, Zhou Y, Pei H, Bai L. Bioinformatic mining and validation of the effects of ferroptosis regulators on the prognosis and progression of pancreatic adenocarcinoma. Gene 2021;795:145804. [PMID: 34175402 DOI: 10.1016/j.gene.2021.145804] [Reference Citation Analysis]
41 Testa U, Pelosi E, Castelli G. New promising developments for potential therapeutic applications of high-dose ascorbate as an anticancer drug. Hematol Oncol Stem Cell Ther 2021;14:179-91. [PMID: 33278349 DOI: 10.1016/j.hemonc.2020.11.002] [Reference Citation Analysis]
42 Hognon C, Bignon E, Harle G, Touche N, Grandemange S, Monari A. The Iron Maiden. Cytosolic Aconitase/IRP1 Conformational Transition in the Regulation of Ferritin Translation and Iron Hemostasis. Biomolecules 2021;11:1329. [PMID: 34572542 DOI: 10.3390/biom11091329] [Reference Citation Analysis]
43 Abedi M, Rahgozar S. Puzzling Out Iron Complications in Cancer Drug Resistance. Crit Rev Oncol Hematol 2022;:103772. [PMID: 35914667 DOI: 10.1016/j.critrevonc.2022.103772] [Reference Citation Analysis]
44 Sacco A, Battaglia AM, Botta C, Aversa I, Mancuso S, Costanzo F, Biamonte F. Iron Metabolism in the Tumor Microenvironment-Implications for Anti-Cancer Immune Response. Cells 2021;10:303. [PMID: 33540645 DOI: 10.3390/cells10020303] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
45 Zhu L, Chen M, Huang B, Zhang T, Chen K, Lian H, Liu M, Zhao K, Pang Y, Zhang J, Li Q, Zhong C. Genomic Analysis Uncovers Immune Microenvironment Characteristics and Drug Sensitivity of Ferroptosis in Breast Cancer Brain Metastasis. Front Genet 2022;12:819632. [DOI: 10.3389/fgene.2021.819632] [Reference Citation Analysis]
46 Sivaprakasam S, Ristic B, Mudaliar N, Hamood AN, Colmer-Hamood J, Wachtel MS, Nevels AG, Kottapalli KR, Ganapathy V. Hereditary hemochromatosis promotes colitis and colon cancer and causes bacterial dysbiosis in mice. Biochem J 2020;477:3867-83. [PMID: 32955078 DOI: 10.1042/BCJ20200392] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
47 Paganoni R, Lechel A, Vujic Spasic M. Iron at the Interface of Hepatocellular Carcinoma. Int J Mol Sci 2021;22:4097. [PMID: 33921027 DOI: 10.3390/ijms22084097] [Reference Citation Analysis]
48 Hui Y, Tang T, Wang J, Zhao H, Yang HY, Xi J, Zhang B, Fang J, Gao K, Wu Y. Fusaricide is a Novel Iron Chelator that Induces Apoptosis through Activating Caspase-3. J Nat Prod 2021;84:2094-103. [PMID: 34292737 DOI: 10.1021/acs.jnatprod.0c01322] [Reference Citation Analysis]
49 Gonciarz RL, Collisson EA, Renslo AR. Ferrous Iron-Dependent Pharmacology. Trends Pharmacol Sci 2021;42:7-18. [PMID: 33261861 DOI: 10.1016/j.tips.2020.11.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
50 Pita-grisanti V, Chasser K, Sobol T, Cruz-monserrate Z. Understanding the Potential and Risk of Bacterial Siderophores in Cancer. Front Oncol 2022;12:867271. [DOI: 10.3389/fonc.2022.867271] [Reference Citation Analysis]
51 Guo H, Nomoto T, Muttaqien SE, Sun X, Komoto K, Matsui M, Miura Y, Nishiyama N. Polymeric Iron Chelators Enhancing Pro-Oxidant Antitumor Efficacy of Vitamin C by Inhibiting the Extracellular Fenton Reaction. Mol Pharm 2021. [PMID: 34726400 DOI: 10.1021/acs.molpharmaceut.1c00673] [Reference Citation Analysis]
52 Huang N, Wei Y, Cheng Y, Wang X, Wang Q, Chen D, Li W. Iron metabolism protein transferrin receptor 1 involves in cervical cancer progression by affecting gene expression and alternative splicing in HeLa cells. Genes Genom. [DOI: 10.1007/s13258-021-01205-w] [Reference Citation Analysis]
53 You Y, Fan Q, Huang J, Wu Y, Lin H, Zhang Q. Ferroptosis-Related Gene Signature Promotes Ovarian Cancer by Influencing Immune Infiltration and Invasion. J Oncol 2021;2021:9915312. [PMID: 34135962 DOI: 10.1155/2021/9915312] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]